Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes.
about
Antigen processing in vivo and the elicitation of primary CTL responsesMechanisms of HIV protein degradation into epitopes: implications for vaccine designStructural Engineering of pMHC Reagents for T Cell Vaccines and DiagnosticsImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseHuman cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virusProtection against a lethal avian influenza A virus in a mammalian system.Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen.A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma.Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades.The specificity of proteasomes: impact on MHC class I processing and presentation of antigens.Proteolysis and class I major histocompatibility complex antigen presentation.Generating MHC class I ligands from viral gene products.Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequencesThe principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequenciesComprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 allelesThe efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen."Troy-bodies": recombinant antibodies that target T cell epitopes to antigen presenting cells.Immunodomination during peripheral vaccinia virus infection.Hydrophobicity as a driver of MHC class I antigen processing.The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy.Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus.Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virusAntiviral protective immunity induced by major histocompatibility complex class I molecule-restricted viral T-lymphocyte epitopes inserted in various positions in immunologically self and nonself proteins.Identification of a T-helper cell epitope on the rotavirus VP6 protein.Portable flanking sequences modulate CTL epitope processing.Use of proteomics to define targets of T-cell immunity.Extracellular processing of peptide antigens that bind class I major histocompatibility moleculesImpaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF proteinVirus escape from CTL recognitionT cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading framesDifferential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections.
P2860
Q24675502-2C672E32-8EB7-4070-A866-63397E02EB8FQ26866505-88DD1E0B-330E-4882-AF41-AB7112F43C58Q27647545-0656814C-383E-4168-B668-9306EC2C00FCQ28238379-B5E468D6-4985-4433-BF46-BD7FC4AEC61EQ30355817-8B27B09D-ED42-47CD-833B-75C629B299DCQ30432414-C5ACDFD0-8E73-442C-96F7-F6322E97A3AAQ30452613-88AEDCA6-D8F2-400A-B883-2059244CC6F5Q30452642-4CD8299A-019C-4B80-B60F-39A7D71F82DBQ30865419-2A9740C8-DC5F-4623-93FB-AAFB2F8EE4DCQ33698112-14DBB051-1268-4DE3-BBE0-D4FFF33A00EDQ33754153-2B1AB83B-A4D9-44AB-8A43-017F157C23A9Q33782497-8DA5264F-BEA8-4F2D-8B00-9B5D3D46870FQ33815363-4666C639-71E2-4C1A-9C74-BD2434749249Q33815369-01B85AE2-E0CE-4B60-9459-13969AF1AB90Q33815388-1F1DA761-4C06-4743-B945-B37EE4991DE1Q33825216-6526CB2A-6D43-413C-95D4-581A124E0F71Q33943143-5B5DFE07-AD90-4933-B350-898BCEABF2A4Q34069815-A346A256-6C6A-42E5-8DA8-589E5F9C4280Q34069951-78D0D0CF-CBFD-4322-A984-D2C16AAA13B0Q34158340-984EEF6C-86FB-4A61-932D-4A63DC4406BCQ34200151-1418612E-4042-4452-B3A3-3FFD150CF949Q34304888-A804E684-AAC3-4CE6-8BFE-6A7794FB7AB6Q34339044-1D25AB4F-1F83-4BE7-8C2E-CABD7F77BB6BQ34482074-61E67835-C30E-48DE-8A00-5271BCDB976AQ34560537-179FCDE0-90C3-4395-9441-F60D460C9B01Q34697921-736188C7-04C1-448E-993C-3040FE33B9CCQ35007960-686F73E0-9E3B-4127-BC08-A415E3A4DB0DQ35417571-C39E8647-7FA7-4515-9A7D-5E0EE93CD71EQ35833059-D915A893-6799-496E-B3A6-1CE72C322345Q35837479-EB2261CC-9810-48F1-BE00-9423F82B1FCDQ35838303-4CCF95AE-81C5-4972-A0EA-A71BBD787D39Q35874990-AD4BCACA-ACB8-4A38-8048-D539583C8266Q36099407-235BA82D-9862-43C4-9DB1-B345AA43A054Q36184807-E95EBE07-4031-4943-B2F1-CEC5FCCE1D82Q36231285-06505430-E71C-4FC4-BBBA-04749AD1EF2EQ36363624-7B2263F4-E413-4835-9D0B-C835F29C200EQ36363636-85093287-6D19-4453-A381-4A345FB9B09FQ36366511-2A710C22-1F7E-4098-9920-88F527A8D979Q36367448-3AB75723-70C8-46DC-9EFF-AB1F296BF8A3Q36371363-4543AB0D-504F-4E79-B9D4-B7897B9B2AFB
P2860
Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Flanking sequences influence t ...... de to cytotoxic T lymphocytes.
@ast
Flanking sequences influence t ...... de to cytotoxic T lymphocytes.
@en
type
label
Flanking sequences influence t ...... de to cytotoxic T lymphocytes.
@ast
Flanking sequences influence t ...... de to cytotoxic T lymphocytes.
@en
prefLabel
Flanking sequences influence t ...... de to cytotoxic T lymphocytes.
@ast
Flanking sequences influence t ...... de to cytotoxic T lymphocytes.
@en
P2093
P2860
P356
P1476
Flanking sequences influence t ...... de to cytotoxic T lymphocytes.
@en
P2093
Bennink JR
Eisenlohr LC
Yewdell JW
P2860
P304
P356
10.1084/JEM.175.2.481
P407
P577
1992-02-01T00:00:00Z